[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Dyne_tx Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1080495985304973314.png) @Dyne_tx Dyne Therapeutics

Dyne Therapeutics posts on X about $dyn, breakthrough, has been, japan the most. They currently have XXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1080495985304973314/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1080495985304973314/c:line/m:interactions.svg)

- X Week XXX -XX%
- X Month XXXXX +50%
- X Months XXXXXX +5.60%
- X Year XXXXXX -XX%

### Mentions: X [#](/creator/twitter::1080495985304973314/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1080495985304973314/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX -XX%
- X Months XX -XX%
- X Year XXX +51%

### Followers: XXXXX [#](/creator/twitter::1080495985304973314/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1080495985304973314/c:line/m:followers.svg)

- X Week XXXXX +0.16%
- X Month XXXXX +0.56%
- X Months XXXXX +7.10%
- X Year XXXXX +9.80%

### CreatorRank: undefined [#](/creator/twitter::1080495985304973314/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1080495985304973314/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1080495985304973314/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXXX% [countries](/list/countries)  XXXX%

**Social topic influence**
[$dyn](/topic/$dyn) #10, [breakthrough](/topic/breakthrough) 1.33%, [has been](/topic/has-been) 1.33%, [japan](/topic/japan) XXXX%

**Top accounts mentioned or mentioned by**
[@myotonicstrong](/creator/undefined) [@checkorphan](/creator/undefined) [@cureduchenne](/creator/undefined) [@jettfoundation](/creator/undefined) [@parentprojectmd](/creator/undefined) [@mdaorg](/creator/undefined) [@usfda](/creator/undefined) [@parentprojectmds](/creator/undefined) [@muscleandnerve](/creator/undefined) [@jasonpaulrhodes](/creator/undefined) [@atlasventure](/creator/undefined) [@pegsboston](/creator/undefined) [@icnmdcongress](/creator/undefined) [@dynetx](/creator/undefined) [@roche](/creator/undefined) [@trindsnmd](/creator/undefined) [@wonderfundma](/creator/undefined) [@treatnmd](/creator/undefined) [@worldsymposia](/creator/undefined) [@parentproject](/creator/undefined)

**Top assets mentioned**
[Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn)
### Top Social Posts [#](/creator/twitter::1080495985304973314/posts)
---
Top posts by engagements in the last XX hours

"Were pleased to share new positive data from our Phase 1/2 DELIVER trial of DYNE-251 in DMD at the @MDAorg Conference. Learn more: $DYN"  
[X Link](https://x.com/Dyne_tx/status/1901600682899353668) [@Dyne_tx](/creator/x/Dyne_tx) 2025-03-17T11:45Z 1250 followers, XXX engagements


"Today we shared our Q2 2025 results highlighting progress for our #DMD and #DM1 programs. Read here: $DYN"  
[X Link](https://x.com/Dyne_tx/status/1949927871377449004) [@Dyne_tx](/creator/x/Dyne_tx) 2025-07-28T20:20Z 1250 followers, XXX engagements


"Today we announced that the @US_FDA has granted Breakthrough Therapy Designation to DYNE-251 for the treatment of patients with DMD amenable to exon XX skipping. Read here:"  
[X Link](https://x.com/Dyne_tx/status/1952348821700120651) [@Dyne_tx](/creator/x/Dyne_tx) 2025-08-04T12:40Z 1250 followers, XXX engagements


"Sarahs family lives with #DM1 across generations. On #MytonicDystrophy Awareness Day we share her story and journey with DM1. Watch the full video:"  
[X Link](https://x.com/Dyne_tx/status/1967588279236034564) [@Dyne_tx](/creator/x/Dyne_tx) 2025-09-15T13:56Z 1250 followers, XXX engagements


"Today we mark the 5th Annual International #MyotonicDystrophy Awareness Day. At Dyne were honored to be a member of the Global Alliance for Myotonic Dystrophy to help raise awareness and advance research. Learn more:"  
[X Link](https://x.com/Dyne_tx/status/1967642343609082121) [@Dyne_tx](/creator/x/Dyne_tx) 2025-09-15T17:31Z 1250 followers, XXX engagements


"DYNE-251 has been granted Orphan Drug designation in Japan for the treatment of patients with #Duchenne muscular dystrophy (#DMD) who have mutations in the DMD gene that are amenable to exon XX skipping. Read here:"  
[X Link](https://x.com/Dyne_tx/status/1972644303873712392) [@Dyne_tx](/creator/x/Dyne_tx) 2025-09-29T12:47Z 1250 followers, XXX engagements


"Data from the ongoing Phase 1/2 ACHIEVE trial in DM1 to be presented at the Congress of the @WorldMuscleSoc continue to demonstrate a favorable safety and efficacy profile for zeleciment basivarsen (formerly known as DYNE-101). See the data:"  
[X Link](https://x.com/Dyne_tx/status/1975321446650991006) [@Dyne_tx](/creator/x/Dyne_tx) 2025-10-06T22:05Z 1250 followers, XXX engagements


"Kathleen Tregoning joined us for our FORCEs in Biotech series sharing insights on government affairs: Government affairs isnt bowlingits billiards. Every move every conversation every engagement bounces off another. Its all connected"  
[X Link](https://x.com/Dyne_tx/status/1978484034243039739) [@Dyne_tx](/creator/x/Dyne_tx) 2025-10-15T15:32Z 1249 followers, XXX engagements